CN102368904B - 甘油单脂肪酸酯组合物 - Google Patents

甘油单脂肪酸酯组合物 Download PDF

Info

Publication number
CN102368904B
CN102368904B CN201080012652.7A CN201080012652A CN102368904B CN 102368904 B CN102368904 B CN 102368904B CN 201080012652 A CN201080012652 A CN 201080012652A CN 102368904 B CN102368904 B CN 102368904B
Authority
CN
China
Prior art keywords
use according
composition
present
amount
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080012652.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN102368904A (zh
Inventor
J.莱恩
B.亨特
E.西亚
H.霍夫兰德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Original Assignee
Stiefel Research Australia Pty Ltd
Stiefel Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42740006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102368904(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Research Australia Pty Ltd, Stiefel Laboratories Inc filed Critical Stiefel Research Australia Pty Ltd
Publication of CN102368904A publication Critical patent/CN102368904A/zh
Application granted granted Critical
Publication of CN102368904B publication Critical patent/CN102368904B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201080012652.7A 2009-03-20 2010-03-19 甘油单脂肪酸酯组合物 Active CN102368904B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20263509P 2009-03-20 2009-03-20
US61/202,635 2009-03-20
US21331309P 2009-05-28 2009-05-28
US61/213,313 2009-05-28
PCT/US2010/027905 WO2010108060A1 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions

Publications (2)

Publication Number Publication Date
CN102368904A CN102368904A (zh) 2012-03-07
CN102368904B true CN102368904B (zh) 2014-03-26

Family

ID=42740006

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080012652.7A Active CN102368904B (zh) 2009-03-20 2010-03-19 甘油单脂肪酸酯组合物

Country Status (15)

Country Link
US (2) US20110305646A1 (https=)
EP (1) EP2408299B1 (https=)
JP (1) JP5992324B2 (https=)
KR (1) KR101506369B1 (https=)
CN (1) CN102368904B (https=)
AU (1) AU2010226476B2 (https=)
BR (1) BRPI1014529A2 (https=)
CA (1) CA2756047C (https=)
CL (1) CL2011002302A1 (https=)
EA (1) EA022569B1 (https=)
ES (1) ES2437395T3 (https=)
IL (1) IL214887A (https=)
MX (1) MX2011009781A (https=)
PL (1) PL2408299T3 (https=)
WO (1) WO2010108060A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138674A1 (en) * 2009-05-29 2010-12-02 Stiefel Laboratories, Inc. Azole antifungal compositions
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
JP6125718B2 (ja) * 2014-03-26 2017-05-10 株式会社マンダム デオドラント組成物及びデオドラント剤
CN104672506A (zh) * 2015-02-02 2015-06-03 安徽玉堂雨具有限公司 一种抗菌防霉生物降解塑料及其制备方法
BR112018075998A2 (pt) * 2016-06-13 2019-04-02 Vyome Therapeutics Limited. composições antifúngicas sinérgicas e métodos das mesmas
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
US20230015225A1 (en) * 2019-12-20 2023-01-19 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Topical pharmaceutical compositions for treating onychomycosis
KR102442047B1 (ko) * 2020-09-10 2022-09-08 서울대학교산학협력단 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465423A2 (en) * 1990-06-25 1992-01-08 Research Foundation for Mental Hygiene, Inc. Antimicrobial fatty compositions
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
US20060029558A1 (en) * 2004-08-03 2006-02-09 Schlievert Patrick M Compositions and methods for controlling infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
RU2122402C1 (ru) * 1995-07-18 1998-11-27 Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
AU2001243189B2 (en) * 2000-02-16 2005-06-09 Cpex Pharmaceuticals, Inc. Pharmaceutical composition
JP2004043336A (ja) * 2002-07-10 2004-02-12 Naris Cosmetics Co Ltd 抗菌剤及びそれを配合してなる化粧料
EP1534763B1 (en) * 2002-07-22 2014-09-10 Ciba Holding Inc. Copolymers and their use in personal care compositions
US20050165104A1 (en) * 2002-07-24 2005-07-28 Holwerda James G. Biocidal agents and veterinary methods
WO2004091567A2 (en) * 2003-04-18 2004-10-28 Merck Patent Gmbh Cosmetic formulations comprising antimicrobial pigments
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
EP2293787A1 (en) * 2008-04-25 2011-03-16 Nanobio Corporation Nanoemulsions for treating fungal, yeast and mold infections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465423A2 (en) * 1990-06-25 1992-01-08 Research Foundation for Mental Hygiene, Inc. Antimicrobial fatty compositions
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
US20060029558A1 (en) * 2004-08-03 2006-02-09 Schlievert Patrick M Compositions and methods for controlling infections

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《Antimicrobial effects of 1-monoacylglycerols prepared by catalytic reaction of glycidol with fatty acids》;ruzicka jan et al;《Eur food res technol》;20030814;第329-331页 *
M Plockova et al.《inhibition of food noulds by lauric acid derivatives》.《V Filip- Advances in food sciences》.1999,第44-47页. *

Also Published As

Publication number Publication date
WO2010108060A1 (en) 2010-09-23
EP2408299B1 (en) 2013-10-23
MX2011009781A (es) 2011-10-17
JP2012521351A (ja) 2012-09-13
CA2756047A1 (en) 2010-09-23
US20110305646A1 (en) 2011-12-15
KR20120014553A (ko) 2012-02-17
US20180360791A1 (en) 2018-12-20
EA022569B1 (ru) 2016-01-29
IL214887A (en) 2015-09-24
ES2437395T3 (es) 2014-01-10
JP5992324B2 (ja) 2016-09-14
CL2011002302A1 (es) 2012-06-22
BRPI1014529A2 (pt) 2015-08-25
IL214887A0 (en) 2011-11-30
KR101506369B1 (ko) 2015-03-30
AU2010226476A1 (en) 2011-09-22
CA2756047C (en) 2016-04-26
CN102368904A (zh) 2012-03-07
EP2408299A4 (en) 2012-08-15
EP2408299A1 (en) 2012-01-25
EA201171150A1 (ru) 2012-03-30
WO2010108060A8 (en) 2011-12-29
PL2408299T3 (pl) 2014-03-31
AU2010226476B2 (en) 2013-02-07

Similar Documents

Publication Publication Date Title
CN102368904B (zh) 甘油单脂肪酸酯组合物
EP4255393B1 (en) Topical roflumilast formulation having antifungal properties
US10828369B2 (en) Compositions and methods for treating diseases of the nail
RU2472510C2 (ru) Стабильная лекарственная форма для местного применения, содержащая вориконазол
CN101641082A (zh) 用于向皮肤释放药物的形成表膜的液体制剂
US20190282501A1 (en) Hydroalcoholic foam formulations of naftifine
HK40118042A (en) Topical roflumilast formulation having antifungal properties
HK40099803A (en) Topical roflumilast formulation having antifungal properties
HK40099803B (en) Topical roflumilast formulation having antifungal properties

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant